diabetes mellitus, type ii
Showing 1 - 25 of 57
Diabetes, Type II, Overweight or Obesity Trial (Shake 1 then Shake 2, Shake 2 then Shake 1)
Not yet recruiting
- Diabetes Mellitus, Type II
- Overweight or Obesity
- Shake 1 then Shake 2
- Shake 2 then Shake 1
- (no location specified)
Jul 13, 2023
Diabetes, Type II Trial in Singapore (16 weeks digital intervention)
Active, not recruiting
- Diabetes Mellitus, Type II
- 16 weeks digital intervention
-
Singapore, SingaporeEVYD Technology Limited
Dec 4, 2022
Diabetes, Type 2, Diabetes, Adult-Onset, Diabetes, Non-Insulin-Dependent Trial in Charleston (Technology Intensified)
Active, not recruiting
- Diabetes Mellitus, Type 2
- +4 more
- Technology Intensified
-
Charleston, South CarolinaMedical University of South Carolina
Apr 4, 2022
Diabetes, Type II Trial in Charleston (Fenofibrate)
Completed
- Diabetes Mellitus, Type II
-
Charleston, South CarolinaMedical University of South Carolina
Jan 11, 2022
Diabetes, Type II Trial in United States (Metformin, Rosiglitazone, Lifestyle Program)
Completed
- Diabetes Mellitus, Type II
- Metformin
- +2 more
-
Los Angeles, California
- +15 more
Jul 28, 2021
Diabetes, Type 2, Diabetes, Adult-Onset, Diabetes, Non-Insulin-Dependent Trial in Charleston (Diabetes Knowledge/Information,
Completed
- Diabetes Mellitus, Type 2
- +4 more
- Diabetes Knowledge/Information
- +3 more
-
Charleston, South CarolinaMedical University of South Carolina
Jun 16, 2021
Diabetes, Type II, Periodontitis Trial in Buffalo (drug, procedure, device)
Completed
- Diabetes Mellitus, Type II
- Periodontitis
- Chlorhexidine gluconate oral rinse
- +2 more
-
Buffalo, New YorkUniversity at Buffalo
Apr 14, 2021
Diabetic Patients: Identification of Treatment Non-Responders
Completed
- Diabetes Mellitus, Type II
- Intensified Treatment of risk factors
-
Graz, AustriaDepartment of Internal Medicine, Medical University of Graz
Feb 25, 2021
Diabetes, Type II, Obesity Trial in Cambridge (MEDI0382, Placebo)
Completed
- Diabetes Mellitus, Type II
- Obesity
- MEDI0382
- Placebo
-
Cambridge, United KingdomResearch Site
Feb 11, 2021
Diabetes, Type II Trial in Asheville (Liraglutide, Insulin)
Completed
- Diabetes Mellitus, Type II
-
Asheville, North CarolinaMountain Diabetes and Endocrine Center
Feb 23, 2021
Diabetes, Type II Trial (Retagliptin, Henagliflozein, metformin XR)
Not yet recruiting
- Diabetes Mellitus, Type II
- Retagliptin, Henagliflozein, metformin XR
- (no location specified)
Dec 9, 2020
Insulin Sensitivity During Hyperbaric Oxygen Compared to
Completed
- Diabetes Mellitus, Type II
- Insulin Resistance
- HBO
- Hyperbaric air
-
Adelaide, South Australia, AustraliaHyperbaric Medicine Unit, Royal Adelaide Hospital
Nov 2, 2020
Diabetes, Type II Trial in Durham (Type 2 Diabetes Self-Management)
Completed
- Diabetes Mellitus, Type II
- Type 2 Diabetes Self-Management
-
Durham, North CarolinaDuke University School of Nursing
Jul 1, 2020
Diabetes, Type 2, Diabetes, Type II, Diabetes, Adult-Onset Trial in Stanford (Victoza (liraglutide) with dietician monitoring,
Completed
- Diabetes Mellitus, Type 2
- +3 more
- Victoza (liraglutide) with dietician monitoring
- Placebo with dietician monitoring
-
Stanford, CaliforniaFreidenrich Center for Translational Research (FCTR)
Jun 6, 2020
Diabetes, Type II, Hypoglycemia, Cognitive Change Trial in Copenhagen (Hypoglycaemic clamp, Euglycaemic clamp)
Completed
- Diabetes Mellitus, Type II
- +2 more
- Hypoglycaemic clamp
- Euglycaemic clamp
-
Copenhagen, DenmarkDepartment of Research in Endocrinology, Bispebjerg University H
Jan 14, 2020
Diabetes, Type II Trial in Barcelona (Walk@WorkApp-Diab)
Unknown status
- Diabetes Mellitus, Type II
- Walk@WorkApp-Diab
-
Barcelona, SpainIDIAP Jordi Gol
Sep 16, 2019
Diabetes, Type II Trial in Jeonju (D308, CKD-501)
Completed
- Diabetes Mellitus, Type II
- D308, CKD-501
-
Jeonju, Korea, Republic ofChonbuk National University Hospital
Nov 15, 2018
Diabetes, Type II Trial in Hanover (Empagliflozin, Glimepiride, Empagliflozin )
Terminated
- Diabetes Mellitus, Type II
- Empagliflozin
- +3 more
-
Hanover, Lower Saxony, GermanyHannover Medical School, University Eye Hospital and CRC Core Fa
Sep 26, 2018
Diabetes, Type II Trial in Saint Louis (Metformin, Rosiglitazone, Lovaza)
Completed
- Diabetes Mellitus, Type II
- Metformin
- +2 more
-
Saint Louis, MissouriWashington University in St. Louis
Aug 24, 2018
Diabetes, Type II Trial in Valparaiso (GOLO RELEASE)
Completed
- Diabetes Mellitus, Type II
- GOLO RELEASE
-
Valparaiso, IndianaBuynak Clinical Research
Mar 23, 2018
Glucose Control on Response to Aspirin in Type 2 Diabetic
Completed
- Diabetes Mellitus, Type II
-
Jerusalem, IsraelHadassah Medical Organization
Aug 9, 2017
Diabetes, Type II Trial in Jeonju-si (Duvie Tab. 0.5mg, Glucophage XR Tab. 500mg, CKD-395 0.25/500mg)
Completed
- Diabetes Mellitus, Type II
- Duvie Tab. 0.5mg, Glucophage XR Tab. 500mg
- CKD-395 0.25/500mg
-
Jeonju-si, Jeollabuk-do, Korea, Republic ofChonbuk National University Hospital
Aug 8, 2017
Diabetes, Type II Trial in Cairo (zinc supplement plus vitamin A and E, vitamin A and E)
Completed
- Diabetes Mellitus, Type II
- zinc supplement plus vitamin A and E
- vitamin A and E
-
Cairo, Egypttheoutpatient clinics, department of internal medicine, Cairo Un
Aug 6, 2017
Diabetes, Type II, Insulin Resistance Trial in Bethesda, Richmond (Exercise cardiopulmonary metabolic testing, Skeletal muscle
Completed
- Diabetes Mellitus, Type II
- Insulin Resistance
- Exercise cardiopulmonary metabolic testing
- +2 more
-
Bethesda, Maryland
- +1 more
Jun 30, 2017
Diabetes, Type 2, Diabetes, Adult-Onset, Diabetes, Non-Insulin-Dependent Trial in Charleston (Tablets Intervention)
Completed
- Diabetes Mellitus, Type 2
- +4 more
- Tablets Intervention
-
Charleston, South CarolinaMedical University of South Carolina
May 5, 2017